Local Laboratory Testing of Germline BRCA Mutations vs. Myriad: A Single-Institution Experience in Korea

Genetic diagnosis for human epidermal growth factor receptor 2-negative metastatic breast cancer patients with the germline BRCA (gBRCA) mutation has been emphasized since the development of polyadenosine diphosphate-ribose polymerase inhibitors. Myriad Genetics, Inc.’s (Salt Lake City, UT, USA) com...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Joohyun, Lee, Jiyun, Kwon, Minsuk, Kim, Ji-Yeon, Kim, Jong-Won, Ahn, Jin Seok, Im, Young-Hyuck, Park, Yeon Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926822/
https://www.ncbi.nlm.nih.gov/pubmed/33671539
http://dx.doi.org/10.3390/diagnostics11020370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926822/
https://www.ncbi.nlm.nih.gov/pubmed/33671539
http://dx.doi.org/10.3390/diagnostics11020370

Ejemplares similares